|
Home 
Featured Discussion
ACR Scientific Meeting 2003
Monday Headlines
ACR Scientific Meeting 2003- Monday Headlines
Just click on a headline to head the
full article
Small
Boosts in Bone Density Matter
Centocor
grant to launch rheumatic medicine research program
Study
Finds That New Laboratory Tests From Prometheus Laboratories May Enable
Doctors to Individualize Rheumatoid Arthritis Therapy
Clinical
Trial Finds Help for Some Lupus Sufferers
ACR:
Magnetic Resonance Imaging of Hand and Forefeet May Be an Effective
Diagnostic Tool for Detection of Early Rheumatoid Arthritis
ACR:
Symptom Benefit for Rheumatoid Arthritis Patients May be Achieved with
Either Budesonide 9 mg or Prednisolone 7.5 mg Daily
ACR:
Rapid Improvement of the Individual Components in ACR20 Responders With
Adalimumab (Humira)
New
Data Show Abbott Laboratories' HUMIRA(R) (Adalimumab) Significantly
Improves Quality of Life in Rheumatoid Arthritis Patients
Abbott
Laboratories Expands HUMIRA(R) (adalimumab) Clinical Trial Program In
Psoriatic Arthritis
AtheroGenics
Initiates Phase II Clinical Trial of AGIX-4207 in Rheumatoid Arthritis
Researchers
Determine a Contributing Genetic Factor of Photosensitivity in Lupus
Patients
Data
Presented at American College of Rheumatology Shows Significant
Reduction In Severity of Experimental Arthritis
Patients
With Acute Musculoskeletal Spasm Experience Significant Improvement In
Physical Functioning With Flexeril 5 Mg
New
Drug Tackles Lupus Nephritis
Cholesterol
Drugs Offer Hope Against Rheumatoid Arthritis
Less-Toxic
Drug for Lupus
Follow-up
Data from Phase II Study of Rituxan
Roche,
Genentech drug helps arthritis long-term
Newer
rheumatoid arthritis drugs: Harmful on the liver?
Centocor
Sponsors Innovative Technology Program to Improve Patient And Physician
Communication and Outcomes in Rheumatology
La
Jolla Pharmaceutical Company Presents Five Posters at American College
of Rheumatology
Isis
Pharmaceuticals Updates Positive Clinical Data on Multiple Antisense
Drugs
Antibiotic
for Knee Osteoarthritis
Aspreva
takes drug in new direction
New
Hope for Children with Arthritis
Roche,
Genentech Drug Helps Arthritis Long-Term
Positive
Preclinical Results for Active Biotech's Project 57-57 for the Treatment
of SLE
Unique
Agreement Between Roche and Aspreva to Develop CellCept In Autoimmune
Diseases
|
